Revvity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Revvity and other ETFs, options, and stocks.

About RVTY

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. 

CEO
Prahlad Ramadhar Singh
CEOPrahlad Ramadhar Singh
Employees
11,000
Employees11,000
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1937
Founded1937
Employees
11,000
Employees11,000

RVTY Key Statistics

Market cap
17.56B
Market cap17.56B
Price-Earnings ratio
71.97
Price-Earnings ratio71.97
Dividend yield
0.18%
Dividend yield0.18%
Average volume
2.24M
Average volume2.24M
High today
$159.05
High today$159.05
Low today
$159.00
Low today$159.00
Open price
$151.75
Open price$151.75
Volume
1.67K
Volume1.67K
52 Week high
$159.05
52 Week high$159.05
52 Week low
$81.22
52 Week low$81.22

Stock Snapshot

Revvity(RVTY) stock is priced at $159.05, giving the company a market capitalization of 17.56B. It carries a P/E multiple of 71.97 and pays a dividend yield of 0.18%.

As of 2026-10-06, Revvity(RVTY) stock has fluctuated between $159.00 and $159.05. The current price stands at $159.05, placing the stock +0.0% above today's low and 0.0% off the high.

The Revvity(RVTY)'s current trading volume is 1.67K, compared to an average daily volume of 2.24M.

In the last year, Revvity(RVTY) shares hit a 52-week high of $159.05 and a 52-week low of $81.22.

In the last year, Revvity(RVTY) shares hit a 52-week high of $159.05 and a 52-week low of $81.22.

RVTY News

MarketWatch 15h
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 16h
How Child Diabetes Screening Launch At Revvity Has Changed Its Investment Story

Revvity launched the CE-IVDR-certified GSP T1D 3plex kit, an automated multiplex autoantibody assay that uses dried blood spots to support population-wide scree...

How Child Diabetes Screening Launch At Revvity Has Changed Its Investment Story

Analyst ratings

62%

of 21 ratings
Buy
28.6%
Hold
61.9%
Sell
9.5%

People also own

Based on the portfolios of people who own RVTY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.